|
| |
Price : 5 slides for 600 €
General Information of the Tissue Array Slide
Applications
- Immunohistochemistry
- In situ hybridization, RNA or DNA
- Fluorescent in situ hybridization (FISH)
- In situ PCR, RNA or DNA
- TUNEL for apoptosis
Storage and stability
- Individual slide is paraffin-coated and put in an air-tight pack
with inert gas.
- Tissue array slides are shipped in room temperature.
- If the slides are stored in 4 degree, they are good up to one
year.
How processed
- Tissues were initially fixed with formalin except for some of the
animal tissues.
- Then, dehydrated with gradient ethanol; typically 1 hour each
progressive steps; 70%, 90%, 95%, 99%, 100% x 3 times.
- Cleared by xylene, three changes for 1 hour each.
- Infiltrated with 60°C paraffin, three changes for 1 hour each
- Microtoming in 4 µm thickness and put on silane coating slide from
Muto Pure Chemicals (Japan)
Before use
- Dry slides for 1 hour in a oven at 60 degree.
- Dewax slides in xylene for 4 minutes x 5 times
- Hydrate slides in 100%, 95% and 75% ethanol for 3 minutes x 2
times each.
- Immerse slides in tap water for 5 minutes
Slide orientation
- In most of the slides with 59 or 60 cores, the orientation is as
below unless indicated otherwise. #60 location is usually filled with carbon
for orientation.
| 1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
| 11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
| 21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
| 31 |
32 |
33 |
34 |
35 |
36 |
37 |
38 |
39 |
40 |
| 41 |
42 |
43 |
44 |
45 |
46 |
47 |
48 |
49 |
50 |
| 51 |
52 |
53 |
54 |
55 |
56 |
57 |
58 |
59 |
60 |
| BC5 Normal organs and cancers |
| |
|
|
|
|
| |
Age |
Sex |
organ |
Diagnosis |
| 1 |
63 |
F |
skin |
normal |
| 2 |
44 |
F |
breast |
normal |
| 3 |
53 |
F |
spleen |
normal |
| 4 |
55 |
M |
lymph node |
normal |
| 5 |
57 |
M |
skeletal muscle |
normal |
| 6 |
72 |
F |
lung |
normal |
| 7 |
69 |
M |
salivary gland, sublingual |
normal |
| 8 |
47 |
M |
liver |
normal |
| 9 |
65 |
M |
gallbladder |
normal |
| 10 |
73 |
F |
pancreas |
normal |
| 11 |
24 |
M |
tonsil |
normal |
| 12 |
56 |
M |
esophagus |
normal |
| 13 |
31 |
M |
stomach, antrum |
normal |
| 14 |
59 |
M |
stomach, fundus |
normal |
| 15 |
52 |
F |
small bowel |
normal |
| 16 |
60 |
M |
colon |
normal |
| 17 |
54 |
M |
rectum |
normal |
| 18 |
48 |
M |
kidney, cortex |
normal |
| 19 |
48 |
M |
kidney, medulla |
normal |
| 20 |
32 |
M |
bladder |
normal |
| 21 |
32 |
M |
prostate |
normal |
| 22 |
81 |
M |
testis |
normal |
| 23 |
39 |
F |
uterine cervix |
normal |
| 24 |
49 |
F |
endometrium |
normal, proliferative |
| 25 |
42 |
F |
myometrium |
normal |
| 26 |
35 |
F |
placenta |
normal |
| 27 |
48 |
M |
adrenal |
normal |
| 28 |
39 |
M |
thyroid |
normal |
| 29 |
0 |
M |
brain |
normal |
| 30 |
12 |
M |
cerebellum |
normal |
| 31 |
57 |
M |
skin |
squamous cell carcinoma |
| 32 |
64 |
F |
skin |
malignant melanoma |
| 33 |
38 |
M |
subcutaneous tissue |
liposarcoma, myxoid |
| 34 |
34 |
F |
breast |
ductal carcinoma in situ |
| 35 |
43 |
F |
breast |
Infiltrating duct carcinoma |
| 36 |
33 |
F |
lymph node |
Hodgkin's disease |
| 37 |
53 |
F |
bone |
osteosarcoma |
| 38 |
60 |
M |
lung |
adenocarcinoma |
| 39 |
72 |
M |
lung |
squamous cell carcinoma |
| 40 |
63 |
M |
liver |
cholangiocarcinoma |
| 41 |
52 |
M |
liver |
hepatocellular carcinoma |
| 42 |
35 |
F |
liver |
metastatic adenocarcinoma from rectum |
| 43 |
56 |
M |
esophagus |
squamous cell carcinoma |
| 44 |
68 |
F |
stomach |
adenocarcinoma |
| 45 |
52 |
M |
stomach |
malignant lymphoma, B cell |
| 46 |
51 |
F |
stomach |
signet ring cell carcinoma |
| 47 |
61 |
M |
duodenum |
gastrointestinal stromal tumor, malignant |
| 48 |
51 |
M |
sigmoid colon |
adenocarcinoma |
| 49 |
73 |
M |
rectum |
adenocarcinoma |
| 50 |
56 |
M |
kidney |
renal cell carcinoma |
| 51 |
53 |
M |
bladder |
transitional cell carcinoma |
| 52 |
70 |
M |
prostate |
adenocarcinoma |
| 53 |
34 |
M |
testis |
seminoma |
| 54 |
64 |
F |
uterine cervix |
squamous cell carcinoma |
| 55 |
69 |
F |
endometrium |
endometrial carcinoma |
| 56 |
42 |
F |
ovary |
metastatic adenocaricnoma from stomach |
| 57 |
15 |
F |
ovary |
mucinous cystadenocarcinoma |
| 58 |
47 |
F |
ovary |
papillary serous cystadenocarcinoma |
| 59 |
69 |
F |
thyroid |
papillary carcinoma |
| 60 |
carbon |
|